William T Abraham Selected Research

Cardiac Resynchronization Therapy

1/2022	The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies.
10/2021	Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure: How to Select the Right Candidate?
1/2021	Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
12/2020	The Use of MitraClip in Secondary Mitral Regurgitation and Heart Failure.
1/2020	Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
1/2020	Future research prioritization in cardiac resynchronization therapy.
11/2019	Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial.
1/2018	Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
1/2018	Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
3/2017	Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William T Abraham Research Topics

Disease

255	Heart Failure 07/2022 - 01/2002
27	Mitral Valve Insufficiency (Mitral Regurgitation) 07/2022 - 04/2006
25	Left Ventricular Dysfunction 10/2021 - 01/2002
11	Hypertension (High Blood Pressure) 05/2022 - 01/2003
11	Atrial Fibrillation 02/2022 - 09/2004
10	Cardiomyopathies (Cardiomyopathy) 01/2020 - 11/2002
10	Dyspnea (Shortness of Breath) 10/2009 - 07/2002
9	Ventricular Remodeling 03/2015 - 01/2005
8	Myocardial Infarction 09/2018 - 01/2003
7	Hyponatremia 06/2013 - 04/2006
6	Systolic Heart Failure 10/2013 - 04/2003
5	Diabetes Mellitus 01/2020 - 01/2004
5	Anemia 01/2020 - 11/2005
4	Neoplasms (Cancer) 05/2022 - 03/2015
4	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2018
4	Obesity 11/2021 - 02/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2003
4	Body Weight (Weight, Body) 01/2017 - 08/2007
4	Ventricular Tachycardia 04/2012 - 01/2007
3	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2021 - 01/2018
3	Apnea 01/2021 - 01/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2018 - 04/2011
3	Hypotension (Low Blood Pressure) 01/2018 - 04/2004
3	Disease Progression 01/2017 - 11/2004
3	Lung Diseases (Lung Disease) 10/2008 - 02/2003
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2007 - 05/2002
3	Hypertrophy 05/2007 - 05/2002
3	Cardiomegaly (Heart Hypertrophy) 06/2005 - 03/2003
2	Chronic Renal Insufficiency 01/2020 - 06/2015
2	Fibrosis (Cirrhosis) 02/2016 - 09/2003
2	Inflammation (Inflammations) 09/2015 - 09/2013
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2013 - 11/2007
2	Renal Insufficiency (Renal Failure) 05/2007 - 11/2005
2	Cardiac Arrhythmias (Arrythmia) 10/2004 - 09/2004
1	Breast Neoplasms (Breast Cancer) 05/2022
1	Cardiotoxicity 05/2022
1	Bradycardia 02/2022

Drug/Important Bio-Agent (IBA)

32	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2002
11	DiureticsIBA 01/2022 - 04/2004
11	CreatinineIBA 08/2021 - 01/2004
10	Carvedilol (Coreg)FDA LinkGeneric 09/2008 - 01/2002
9	SodiumIBA 11/2021 - 04/2007
9	aliskiren FDA Link 08/2021 - 01/2011
7	Pharmaceutical PreparationsIBA 05/2022 - 01/2005
7	bucindololIBA 02/2022 - 01/2010
7	Vasodilator Agents (Vasodilators)IBA 01/2018 - 04/2004
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2016 - 03/2002
6	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2015
5	Metoprolol (Toprol-XL)FDA LinkGeneric 02/2022 - 05/2002
5	Oxygen (Dioxygen)IBA 01/2021 - 01/2008
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2016 - 01/2002
5	lixivaptanIBA 12/2012 - 04/2006
4	Enalapril FDA LinkGeneric 08/2021 - 01/2011
4	Natriuretic PeptidesIBA 01/2021 - 10/2015
4	ReninIBA 01/2011 - 01/2003
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2010 - 11/2002
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2010 - 01/2002
4	AldosteroneIBA 03/2009 - 01/2003
4	Hemoglobins (Hemoglobin)IBA 10/2008 - 06/2005
3	empagliflozinIBA 11/2021 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2018
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018 - 05/2002
3	Vasopressins (Vasopressin)IBA 12/2012 - 10/2010
3	ElectrolytesIBA 12/2012 - 10/2010
3	Adenosine (Adenocard)FDA LinkGeneric 06/2011 - 03/2002
3	Darbepoetin alfa (Aranesp)FDA Link 05/2010 - 01/2008
3	AngiotensinsIBA 03/2009 - 01/2003
2	Mineralocorticoid Receptor AntagonistsIBA 07/2022 - 01/2005
2	sacubitril and valsartan sodium hydrate drug combinationIBA 08/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 05/2007
2	UlaritideIBA 01/2017 - 01/2017
2	Blood Glucose (Blood Sugar)IBA 09/2015 - 03/2004
2	SympatholyticsIBA 08/2013 - 01/2010
2	Arginine Vasopressin (Argipressin)IBA 12/2012 - 04/2006
2	BG 9928IBA 06/2011 - 08/2007
2	Antidiuretic Hormone Receptor AntagonistsIBA 10/2010 - 04/2006
2	EnoximoneIBA 12/2009 - 11/2007
2	Indicators and Reagents (Reagents)IBA 10/2009 - 11/2007
2	Angiotensin Receptor AntagonistsIBA 10/2008 - 01/2007
2	Messenger RNA (mRNA)IBA 05/2007 - 05/2002
2	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 05/2007 - 05/2002
2	Ventricular MyosinsIBA 05/2007 - 05/2002
2	Atrial Natriuretic Factor (ANF)IBA 05/2007 - 05/2002
2	Protein Isoforms (Isoforms)IBA 05/2007 - 05/2002
2	beta Adrenergic ReceptorsIBA 09/2005 - 05/2002
1	eribulin FDA Link 05/2022

Therapy/Procedure

148	Therapeutics 07/2022 - 01/2002
68	Cardiac Resynchronization Therapy 01/2022 - 06/2002
10	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2016 - 05/2003
9	Length of Stay 06/2015 - 07/2004
8	Patient Readmission 05/2017 - 01/2007
7	Defibrillators (Defibrillator) 01/2020 - 01/2007
4	Drug Therapy (Chemotherapy) 05/2022 - 01/2002
4	Lung Transplantation 04/2009 - 09/2005
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2018 - 04/2011
2	Heart-Assist Devices 05/2018 - 11/2007
2	Decompression 05/2015 - 01/2015
2	Transplantation 02/2013 - 02/2004
2	Catheters 04/2009 - 11/2008
2	Continuous Positive Airway Pressure 12/2008 - 07/2008